nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Imiquimod—skin cancer	0.143	0.233	CbGbCtD
Darifenacin—CYP3A4—Temozolomide—skin cancer	0.143	0.233	CbGbCtD
Darifenacin—CYP2D6—Vemurafenib—skin cancer	0.123	0.201	CbGbCtD
Darifenacin—CYP3A4—Vismodegib—skin cancer	0.0989	0.162	CbGbCtD
Darifenacin—CYP3A4—Vemurafenib—skin cancer	0.0781	0.128	CbGbCtD
Darifenacin—CYP3A4—Docetaxel—skin cancer	0.0268	0.0438	CbGbCtD
Darifenacin—CHRM3—muscle of abdomen—skin cancer	0.00345	0.34	CbGeAlD
Darifenacin—CHRM5—skin epidermis—skin cancer	0.00226	0.222	CbGeAlD
Darifenacin—Mediastinal disorder—Imiquimod—skin cancer	0.00175	0.00464	CcSEcCtD
Darifenacin—Cough—Vemurafenib—skin cancer	0.00173	0.00458	CcSEcCtD
Darifenacin—Mental disorder—Imiquimod—skin cancer	0.0017	0.00451	CcSEcCtD
Darifenacin—Arthralgia—Vemurafenib—skin cancer	0.00169	0.00447	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00168	0.00444	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00168	0.00444	CcSEcCtD
Darifenacin—Vomiting—Vismodegib—skin cancer	0.00167	0.00441	CcSEcCtD
Darifenacin—Rash—Vismodegib—skin cancer	0.00165	0.00438	CcSEcCtD
Darifenacin—Dermatitis—Vismodegib—skin cancer	0.00165	0.00437	CcSEcCtD
Darifenacin—Back pain—Imiquimod—skin cancer	0.00164	0.00433	CcSEcCtD
Darifenacin—Face oedema—Temozolomide—skin cancer	0.00163	0.0043	CcSEcCtD
Darifenacin—Anaphylactic shock—Vemurafenib—skin cancer	0.00162	0.00429	CcSEcCtD
Darifenacin—Infection—Vemurafenib—skin cancer	0.00161	0.00426	CcSEcCtD
Darifenacin—Nervous system disorder—Vemurafenib—skin cancer	0.00159	0.0042	CcSEcCtD
Darifenacin—Skin disorder—Vemurafenib—skin cancer	0.00157	0.00416	CcSEcCtD
Darifenacin—Nausea—Vismodegib—skin cancer	0.00156	0.00412	CcSEcCtD
Darifenacin—Angioedema—Imiquimod—skin cancer	0.00155	0.00409	CcSEcCtD
Darifenacin—Dry skin—Temozolomide—skin cancer	0.00154	0.00409	CcSEcCtD
Darifenacin—Breast disorder—Temozolomide—skin cancer	0.00152	0.00403	CcSEcCtD
Darifenacin—Syncope—Imiquimod—skin cancer	0.00152	0.00402	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00152	0.00401	CcSEcCtD
Darifenacin—Stomatitis—Bleomycin—skin cancer	0.0015	0.00397	CcSEcCtD
Darifenacin—Palpitations—Imiquimod—skin cancer	0.0015	0.00396	CcSEcCtD
Darifenacin—Loss of consciousness—Imiquimod—skin cancer	0.00149	0.00394	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00149	0.00393	CcSEcCtD
Darifenacin—Cough—Imiquimod—skin cancer	0.00148	0.00391	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00148	0.00391	CcSEcCtD
Darifenacin—Hypertension—Imiquimod—skin cancer	0.00146	0.00387	CcSEcCtD
Darifenacin—Arthralgia—Imiquimod—skin cancer	0.00144	0.00381	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00143	0.00379	CcSEcCtD
Darifenacin—Dry skin—Fluorouracil—skin cancer	0.00142	0.00376	CcSEcCtD
Darifenacin—Dry mouth—Imiquimod—skin cancer	0.00141	0.00373	CcSEcCtD
Darifenacin—Bronchitis—Temozolomide—skin cancer	0.0014	0.00371	CcSEcCtD
Darifenacin—Stomatitis—Dactinomycin—skin cancer	0.0014	0.0037	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.0014	0.0037	CcSEcCtD
Darifenacin—Constipation—Vemurafenib—skin cancer	0.00139	0.00367	CcSEcCtD
Darifenacin—Oedema—Imiquimod—skin cancer	0.00138	0.00366	CcSEcCtD
Darifenacin—Infection—Imiquimod—skin cancer	0.00137	0.00363	CcSEcCtD
Darifenacin—Shock—Imiquimod—skin cancer	0.00136	0.0036	CcSEcCtD
Darifenacin—Nervous system disorder—Imiquimod—skin cancer	0.00135	0.00359	CcSEcCtD
Darifenacin—Tachycardia—Imiquimod—skin cancer	0.00135	0.00357	CcSEcCtD
Darifenacin—Skin disorder—Imiquimod—skin cancer	0.00134	0.00355	CcSEcCtD
Darifenacin—Erectile dysfunction—Temozolomide—skin cancer	0.00134	0.00355	CcSEcCtD
Darifenacin—Hyperhidrosis—Imiquimod—skin cancer	0.00134	0.00353	CcSEcCtD
Darifenacin—Weight increased—Temozolomide—skin cancer	0.00132	0.00351	CcSEcCtD
Darifenacin—Infestation—Temozolomide—skin cancer	0.0013	0.00344	CcSEcCtD
Darifenacin—Infestation NOS—Temozolomide—skin cancer	0.0013	0.00344	CcSEcCtD
Darifenacin—Pharyngitis—Dactinomycin—skin cancer	0.00128	0.00338	CcSEcCtD
Darifenacin—Stomatitis—Temozolomide—skin cancer	0.00127	0.00335	CcSEcCtD
Darifenacin—Urinary tract infection—Temozolomide—skin cancer	0.00126	0.00334	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00126	0.00333	CcSEcCtD
Darifenacin—Insomnia—Imiquimod—skin cancer	0.00125	0.00331	CcSEcCtD
Darifenacin—Dyspnoea—Imiquimod—skin cancer	0.00123	0.00326	CcSEcCtD
Darifenacin—Somnolence—Imiquimod—skin cancer	0.00123	0.00325	CcSEcCtD
Darifenacin—Erythema multiforme—Dactinomycin—skin cancer	0.00122	0.00322	CcSEcCtD
Darifenacin—Sinusitis—Temozolomide—skin cancer	0.00122	0.00322	CcSEcCtD
Darifenacin—Dyspepsia—Imiquimod—skin cancer	0.00122	0.00322	CcSEcCtD
Darifenacin—Infestation—Fluorouracil—skin cancer	0.0012	0.00317	CcSEcCtD
Darifenacin—Infestation NOS—Fluorouracil—skin cancer	0.0012	0.00317	CcSEcCtD
Darifenacin—Hypersensitivity—Vemurafenib—skin cancer	0.00119	0.00316	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00119	0.00316	CcSEcCtD
Darifenacin—Visual disturbance—Docetaxel—skin cancer	0.00118	0.00313	CcSEcCtD
Darifenacin—Pain—Imiquimod—skin cancer	0.00118	0.00313	CcSEcCtD
Darifenacin—Stomatitis—Fluorouracil—skin cancer	0.00117	0.00309	CcSEcCtD
Darifenacin—Urinary tract infection—Fluorouracil—skin cancer	0.00116	0.00308	CcSEcCtD
Darifenacin—Asthenia—Vemurafenib—skin cancer	0.00116	0.00308	CcSEcCtD
Darifenacin—Hallucination—Temozolomide—skin cancer	0.00116	0.00307	CcSEcCtD
Darifenacin—Pharyngitis—Temozolomide—skin cancer	0.00116	0.00306	CcSEcCtD
Darifenacin—Urinary tract disorder—Temozolomide—skin cancer	0.00115	0.00305	CcSEcCtD
Darifenacin—Oedema peripheral—Temozolomide—skin cancer	0.00115	0.00304	CcSEcCtD
Darifenacin—Pruritus—Vemurafenib—skin cancer	0.00115	0.00303	CcSEcCtD
Darifenacin—Urethral disorder—Temozolomide—skin cancer	0.00114	0.00302	CcSEcCtD
Darifenacin—Feeling abnormal—Imiquimod—skin cancer	0.00114	0.00301	CcSEcCtD
Darifenacin—Gastrointestinal pain—Imiquimod—skin cancer	0.00113	0.00299	CcSEcCtD
Darifenacin—Visual impairment—Temozolomide—skin cancer	0.00112	0.00297	CcSEcCtD
Darifenacin—Sinusitis—Fluorouracil—skin cancer	0.00112	0.00297	CcSEcCtD
Darifenacin—Diarrhoea—Vemurafenib—skin cancer	0.00111	0.00293	CcSEcCtD
Darifenacin—Erythema multiforme—Temozolomide—skin cancer	0.0011	0.00292	CcSEcCtD
Darifenacin—Abdominal pain—Imiquimod—skin cancer	0.00109	0.00289	CcSEcCtD
Darifenacin—Eye disorder—Temozolomide—skin cancer	0.00109	0.00288	CcSEcCtD
Darifenacin—Rhinitis—Fluorouracil—skin cancer	0.00108	0.00285	CcSEcCtD
Darifenacin—Dizziness—Vemurafenib—skin cancer	0.00107	0.00283	CcSEcCtD
Darifenacin—Pharyngitis—Fluorouracil—skin cancer	0.00107	0.00282	CcSEcCtD
Darifenacin—Angiopathy—Temozolomide—skin cancer	0.00106	0.0028	CcSEcCtD
Darifenacin—Mediastinal disorder—Temozolomide—skin cancer	0.00105	0.00278	CcSEcCtD
Darifenacin—Cough—Bleomycin—skin cancer	0.00105	0.00278	CcSEcCtD
Darifenacin—Vomiting—Vemurafenib—skin cancer	0.00103	0.00273	CcSEcCtD
Darifenacin—Dry skin—Docetaxel—skin cancer	0.00103	0.00272	CcSEcCtD
Darifenacin—Rash—Vemurafenib—skin cancer	0.00102	0.0027	CcSEcCtD
Darifenacin—Mental disorder—Temozolomide—skin cancer	0.00102	0.0027	CcSEcCtD
Darifenacin—Dermatitis—Vemurafenib—skin cancer	0.00102	0.0027	CcSEcCtD
Darifenacin—Hypersensitivity—Imiquimod—skin cancer	0.00102	0.00269	CcSEcCtD
Darifenacin—Headache—Vemurafenib—skin cancer	0.00101	0.00269	CcSEcCtD
Darifenacin—Breast disorder—Docetaxel—skin cancer	0.00101	0.00268	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00101	0.00267	CcSEcCtD
Darifenacin—Dysgeusia—Temozolomide—skin cancer	0.000993	0.00263	CcSEcCtD
Darifenacin—Asthenia—Imiquimod—skin cancer	0.000991	0.00262	CcSEcCtD
Darifenacin—Confusional state—Bleomycin—skin cancer	0.00099	0.00262	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000988	0.00261	CcSEcCtD
Darifenacin—Anaphylactic shock—Bleomycin—skin cancer	0.000981	0.0026	CcSEcCtD
Darifenacin—Oedema—Bleomycin—skin cancer	0.000981	0.0026	CcSEcCtD
Darifenacin—Back pain—Temozolomide—skin cancer	0.000981	0.0026	CcSEcCtD
Darifenacin—Pruritus—Imiquimod—skin cancer	0.000977	0.00259	CcSEcCtD
Darifenacin—Infection—Bleomycin—skin cancer	0.000975	0.00258	CcSEcCtD
Darifenacin—Nausea—Vemurafenib—skin cancer	0.000962	0.00255	CcSEcCtD
Darifenacin—Vision blurred—Temozolomide—skin cancer	0.000956	0.00253	CcSEcCtD
Darifenacin—Diarrhoea—Imiquimod—skin cancer	0.000945	0.0025	CcSEcCtD
Darifenacin—Angioedema—Temozolomide—skin cancer	0.000927	0.00245	CcSEcCtD
Darifenacin—Oedema—Dactinomycin—skin cancer	0.000915	0.00242	CcSEcCtD
Darifenacin—Dizziness—Imiquimod—skin cancer	0.000914	0.00242	CcSEcCtD
Darifenacin—Infection—Dactinomycin—skin cancer	0.000909	0.00241	CcSEcCtD
Darifenacin—Palpitations—Temozolomide—skin cancer	0.000896	0.00237	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000894	0.00237	CcSEcCtD
Darifenacin—Cough—Temozolomide—skin cancer	0.000885	0.00234	CcSEcCtD
Darifenacin—Weight increased—Docetaxel—skin cancer	0.000881	0.00233	CcSEcCtD
Darifenacin—Vision blurred—Fluorouracil—skin cancer	0.000881	0.00233	CcSEcCtD
Darifenacin—Vomiting—Imiquimod—skin cancer	0.000878	0.00232	CcSEcCtD
Darifenacin—Hypertension—Temozolomide—skin cancer	0.000876	0.00232	CcSEcCtD
Darifenacin—Dyspnoea—Bleomycin—skin cancer	0.000875	0.00232	CcSEcCtD
Darifenacin—Rash—Imiquimod—skin cancer	0.000871	0.00231	CcSEcCtD
Darifenacin—Dermatitis—Imiquimod—skin cancer	0.00087	0.0023	CcSEcCtD
Darifenacin—Headache—Imiquimod—skin cancer	0.000865	0.00229	CcSEcCtD
Darifenacin—Arthralgia—Temozolomide—skin cancer	0.000864	0.00229	CcSEcCtD
Darifenacin—Infestation NOS—Docetaxel—skin cancer	0.000863	0.00228	CcSEcCtD
Darifenacin—Infestation—Docetaxel—skin cancer	0.000863	0.00228	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000858	0.00227	CcSEcCtD
Darifenacin—Dry mouth—Temozolomide—skin cancer	0.000845	0.00224	CcSEcCtD
Darifenacin—Stomatitis—Docetaxel—skin cancer	0.000841	0.00223	CcSEcCtD
Darifenacin—Pain—Bleomycin—skin cancer	0.000839	0.00222	CcSEcCtD
Darifenacin—Confusional state—Temozolomide—skin cancer	0.000835	0.00221	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000834	0.00221	CcSEcCtD
Darifenacin—Oedema—Temozolomide—skin cancer	0.000828	0.00219	CcSEcCtD
Darifenacin—Anaphylactic shock—Temozolomide—skin cancer	0.000828	0.00219	CcSEcCtD
Darifenacin—Infection—Temozolomide—skin cancer	0.000822	0.00218	CcSEcCtD
Darifenacin—Nausea—Imiquimod—skin cancer	0.000821	0.00217	CcSEcCtD
Darifenacin—Nervous system disorder—Temozolomide—skin cancer	0.000812	0.00215	CcSEcCtD
Darifenacin—Feeling abnormal—Bleomycin—skin cancer	0.000809	0.00214	CcSEcCtD
Darifenacin—Skin disorder—Temozolomide—skin cancer	0.000804	0.00213	CcSEcCtD
Darifenacin—Hyperhidrosis—Temozolomide—skin cancer	0.0008	0.00212	CcSEcCtD
Darifenacin—Pain—Dactinomycin—skin cancer	0.000783	0.00207	CcSEcCtD
Darifenacin—Rhinitis—Docetaxel—skin cancer	0.000777	0.00206	CcSEcCtD
Darifenacin—Confusional state—Fluorouracil—skin cancer	0.000769	0.00204	CcSEcCtD
Darifenacin—Pharyngitis—Docetaxel—skin cancer	0.000769	0.00204	CcSEcCtD
Darifenacin—Urinary tract disorder—Docetaxel—skin cancer	0.000765	0.00203	CcSEcCtD
Darifenacin—Oedema peripheral—Docetaxel—skin cancer	0.000763	0.00202	CcSEcCtD
Darifenacin—Oedema—Fluorouracil—skin cancer	0.000763	0.00202	CcSEcCtD
Darifenacin—Anaphylactic shock—Fluorouracil—skin cancer	0.000763	0.00202	CcSEcCtD
Darifenacin—Urethral disorder—Docetaxel—skin cancer	0.00076	0.00201	CcSEcCtD
Darifenacin—Infection—Fluorouracil—skin cancer	0.000758	0.00201	CcSEcCtD
Darifenacin—Feeling abnormal—Dactinomycin—skin cancer	0.000754	0.002	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000754	0.002	CcSEcCtD
Darifenacin—Insomnia—Temozolomide—skin cancer	0.000749	0.00198	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000748	0.00198	CcSEcCtD
Darifenacin—Nervous system disorder—Fluorouracil—skin cancer	0.000748	0.00198	CcSEcCtD
Darifenacin—Visual impairment—Docetaxel—skin cancer	0.000747	0.00198	CcSEcCtD
Darifenacin—Tachycardia—Fluorouracil—skin cancer	0.000744	0.00197	CcSEcCtD
Darifenacin—Dyspnoea—Temozolomide—skin cancer	0.000738	0.00195	CcSEcCtD
Darifenacin—Somnolence—Temozolomide—skin cancer	0.000736	0.00195	CcSEcCtD
Darifenacin—CHRM5—epithelium—skin cancer	0.000735	0.0724	CbGeAlD
Darifenacin—Erythema multiforme—Docetaxel—skin cancer	0.000733	0.00194	CcSEcCtD
Darifenacin—Dyspepsia—Temozolomide—skin cancer	0.000729	0.00193	CcSEcCtD
Darifenacin—Eye disorder—Docetaxel—skin cancer	0.000724	0.00192	CcSEcCtD
Darifenacin—Abdominal pain—Dactinomycin—skin cancer	0.000724	0.00191	CcSEcCtD
Darifenacin—Hypersensitivity—Bleomycin—skin cancer	0.000723	0.00191	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000715	0.00189	CcSEcCtD
Darifenacin—Constipation—Temozolomide—skin cancer	0.000708	0.00187	CcSEcCtD
Darifenacin—Pain—Temozolomide—skin cancer	0.000708	0.00187	CcSEcCtD
Darifenacin—Asthenia—Bleomycin—skin cancer	0.000704	0.00186	CcSEcCtD
Darifenacin—Angiopathy—Docetaxel—skin cancer	0.000703	0.00186	CcSEcCtD
Darifenacin—CHRM5—skin of body—skin cancer	0.000699	0.0688	CbGeAlD
Darifenacin—Mediastinal disorder—Docetaxel—skin cancer	0.000698	0.00185	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000695	0.00184	CcSEcCtD
Darifenacin—Pruritus—Bleomycin—skin cancer	0.000694	0.00184	CcSEcCtD
Darifenacin—Insomnia—Fluorouracil—skin cancer	0.00069	0.00183	CcSEcCtD
Darifenacin—Feeling abnormal—Temozolomide—skin cancer	0.000682	0.00181	CcSEcCtD
Darifenacin—Dyspnoea—Fluorouracil—skin cancer	0.00068	0.0018	CcSEcCtD
Darifenacin—Mental disorder—Docetaxel—skin cancer	0.000679	0.0018	CcSEcCtD
Darifenacin—Somnolence—Fluorouracil—skin cancer	0.000678	0.00179	CcSEcCtD
Darifenacin—Gastrointestinal pain—Temozolomide—skin cancer	0.000677	0.00179	CcSEcCtD
Darifenacin—Hypersensitivity—Dactinomycin—skin cancer	0.000674	0.00178	CcSEcCtD
Darifenacin—Dyspepsia—Fluorouracil—skin cancer	0.000671	0.00178	CcSEcCtD
Darifenacin—Dysgeusia—Docetaxel—skin cancer	0.000661	0.00175	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000659	0.00174	CcSEcCtD
Darifenacin—Asthenia—Dactinomycin—skin cancer	0.000657	0.00174	CcSEcCtD
Darifenacin—Abdominal pain—Temozolomide—skin cancer	0.000654	0.00173	CcSEcCtD
Darifenacin—Back pain—Docetaxel—skin cancer	0.000653	0.00173	CcSEcCtD
Darifenacin—Pain—Fluorouracil—skin cancer	0.000652	0.00173	CcSEcCtD
Darifenacin—Feeling abnormal—Fluorouracil—skin cancer	0.000629	0.00166	CcSEcCtD
Darifenacin—Diarrhoea—Dactinomycin—skin cancer	0.000626	0.00166	CcSEcCtD
Darifenacin—Vomiting—Bleomycin—skin cancer	0.000624	0.00165	CcSEcCtD
Darifenacin—Rash—Bleomycin—skin cancer	0.000619	0.00164	CcSEcCtD
Darifenacin—Dermatitis—Bleomycin—skin cancer	0.000618	0.00164	CcSEcCtD
Darifenacin—Hypersensitivity—Temozolomide—skin cancer	0.00061	0.00161	CcSEcCtD
Darifenacin—Syncope—Docetaxel—skin cancer	0.000605	0.0016	CcSEcCtD
Darifenacin—Palpitations—Docetaxel—skin cancer	0.000596	0.00158	CcSEcCtD
Darifenacin—Asthenia—Temozolomide—skin cancer	0.000594	0.00157	CcSEcCtD
Darifenacin—Loss of consciousness—Docetaxel—skin cancer	0.000593	0.00157	CcSEcCtD
Darifenacin—Cough—Docetaxel—skin cancer	0.000589	0.00156	CcSEcCtD
Darifenacin—Pruritus—Temozolomide—skin cancer	0.000586	0.00155	CcSEcCtD
Darifenacin—CHRM4—head—skin cancer	0.000584	0.0575	CbGeAlD
Darifenacin—Nausea—Bleomycin—skin cancer	0.000583	0.00154	CcSEcCtD
Darifenacin—Hypertension—Docetaxel—skin cancer	0.000582	0.00154	CcSEcCtD
Darifenacin—Vomiting—Dactinomycin—skin cancer	0.000582	0.00154	CcSEcCtD
Darifenacin—Rash—Dactinomycin—skin cancer	0.000577	0.00153	CcSEcCtD
Darifenacin—Arthralgia—Docetaxel—skin cancer	0.000574	0.00152	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00057	0.00151	CcSEcCtD
Darifenacin—Diarrhoea—Temozolomide—skin cancer	0.000566	0.0015	CcSEcCtD
Darifenacin—Hypersensitivity—Fluorouracil—skin cancer	0.000562	0.00149	CcSEcCtD
Darifenacin—Dry mouth—Docetaxel—skin cancer	0.000562	0.00149	CcSEcCtD
Darifenacin—Confusional state—Docetaxel—skin cancer	0.000555	0.00147	CcSEcCtD
Darifenacin—Anaphylactic shock—Docetaxel—skin cancer	0.000551	0.00146	CcSEcCtD
Darifenacin—Oedema—Docetaxel—skin cancer	0.000551	0.00146	CcSEcCtD
Darifenacin—Dizziness—Temozolomide—skin cancer	0.000547	0.00145	CcSEcCtD
Darifenacin—Infection—Docetaxel—skin cancer	0.000547	0.00145	CcSEcCtD
Darifenacin—Nausea—Dactinomycin—skin cancer	0.000544	0.00144	CcSEcCtD
Darifenacin—Shock—Docetaxel—skin cancer	0.000542	0.00143	CcSEcCtD
Darifenacin—Nervous system disorder—Docetaxel—skin cancer	0.00054	0.00143	CcSEcCtD
Darifenacin—Pruritus—Fluorouracil—skin cancer	0.00054	0.00143	CcSEcCtD
Darifenacin—Tachycardia—Docetaxel—skin cancer	0.000537	0.00142	CcSEcCtD
Darifenacin—Skin disorder—Docetaxel—skin cancer	0.000535	0.00142	CcSEcCtD
Darifenacin—Vomiting—Temozolomide—skin cancer	0.000526	0.00139	CcSEcCtD
Darifenacin—Rash—Temozolomide—skin cancer	0.000522	0.00138	CcSEcCtD
Darifenacin—Diarrhoea—Fluorouracil—skin cancer	0.000522	0.00138	CcSEcCtD
Darifenacin—Dermatitis—Temozolomide—skin cancer	0.000522	0.00138	CcSEcCtD
Darifenacin—Headache—Temozolomide—skin cancer	0.000519	0.00137	CcSEcCtD
Darifenacin—Dizziness—Fluorouracil—skin cancer	0.000504	0.00133	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000502	0.00133	CcSEcCtD
Darifenacin—Insomnia—Docetaxel—skin cancer	0.000498	0.00132	CcSEcCtD
Darifenacin—Nausea—Temozolomide—skin cancer	0.000492	0.0013	CcSEcCtD
Darifenacin—Dyspnoea—Docetaxel—skin cancer	0.000491	0.0013	CcSEcCtD
Darifenacin—Somnolence—Docetaxel—skin cancer	0.000489	0.0013	CcSEcCtD
Darifenacin—Vomiting—Fluorouracil—skin cancer	0.000485	0.00128	CcSEcCtD
Darifenacin—Dyspepsia—Docetaxel—skin cancer	0.000485	0.00128	CcSEcCtD
Darifenacin—Rash—Fluorouracil—skin cancer	0.000481	0.00127	CcSEcCtD
Darifenacin—Dermatitis—Fluorouracil—skin cancer	0.000481	0.00127	CcSEcCtD
Darifenacin—Headache—Fluorouracil—skin cancer	0.000478	0.00126	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000475	0.00126	CcSEcCtD
Darifenacin—Pain—Docetaxel—skin cancer	0.000471	0.00125	CcSEcCtD
Darifenacin—Constipation—Docetaxel—skin cancer	0.000471	0.00125	CcSEcCtD
Darifenacin—CHRM5—head—skin cancer	0.000456	0.0449	CbGeAlD
Darifenacin—Feeling abnormal—Docetaxel—skin cancer	0.000454	0.0012	CcSEcCtD
Darifenacin—Nausea—Fluorouracil—skin cancer	0.000453	0.0012	CcSEcCtD
Darifenacin—Gastrointestinal pain—Docetaxel—skin cancer	0.00045	0.00119	CcSEcCtD
Darifenacin—Abdominal pain—Docetaxel—skin cancer	0.000435	0.00115	CcSEcCtD
Darifenacin—Hypersensitivity—Docetaxel—skin cancer	0.000406	0.00107	CcSEcCtD
Darifenacin—Asthenia—Docetaxel—skin cancer	0.000395	0.00105	CcSEcCtD
Darifenacin—Pruritus—Docetaxel—skin cancer	0.00039	0.00103	CcSEcCtD
Darifenacin—Diarrhoea—Docetaxel—skin cancer	0.000377	0.000997	CcSEcCtD
Darifenacin—Dizziness—Docetaxel—skin cancer	0.000364	0.000963	CcSEcCtD
Darifenacin—Vomiting—Docetaxel—skin cancer	0.00035	0.000926	CcSEcCtD
Darifenacin—Rash—Docetaxel—skin cancer	0.000347	0.000919	CcSEcCtD
Darifenacin—Dermatitis—Docetaxel—skin cancer	0.000347	0.000918	CcSEcCtD
Darifenacin—Headache—Docetaxel—skin cancer	0.000345	0.000913	CcSEcCtD
Darifenacin—CHRM1—female reproductive system—skin cancer	0.000341	0.0336	CbGeAlD
Darifenacin—Nausea—Docetaxel—skin cancer	0.000327	0.000865	CcSEcCtD
Darifenacin—CHRM2—head—skin cancer	0.000313	0.0308	CbGeAlD
Darifenacin—CHRM3—female reproductive system—skin cancer	0.000305	0.0301	CbGeAlD
Darifenacin—CHRM1—head—skin cancer	0.000285	0.0281	CbGeAlD
Darifenacin—CHRM3—head—skin cancer	0.000255	0.0251	CbGeAlD
Darifenacin—CYP3A4—female reproductive system—skin cancer	0.000168	0.0165	CbGeAlD
Darifenacin—CYP2D6—female reproductive system—skin cancer	0.000165	0.0163	CbGeAlD
Darifenacin—CYP2D6—head—skin cancer	0.000138	0.0136	CbGeAlD
